ISPOR Announces Honorees for the 2022 Health Economics and Outcomes Research Awards

Published Sep 13, 2022

Lawrenceville, NJ, USA—September 13, 2022—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2022 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

ISPOR Scientific Awards are designed to foster and recognize excellence and outstanding achievement in HEOR and its Leadership Awards recognize excellence and outstanding leadership in the field. The Society will be hosting a Virtual Awards Ceremony on Tuesday, November 15 from 1:00PM – 2:00PM EST to recognize the honorees.

Avedis Donabedian Lifetime Achievement Award
This award recognizes honorees for their outstanding, life-long contribution to the improvement of health outcomes. The 2022 honoree is:

  • Louis P. Garrison, Jr, PhD; University of Washington; Seattle, WA, USA

     

    Marilyn Dix Smith Leadership Award
    This award recognizes a leader who has shown consistent, broad, and meaningful direction to the Society. The 2022 honoree is:

  • Don Husereau, MSc, BSc; University of Ottawa; Ottawa, Canada

     

    Bernie O’Brien New Investigator Award
    This award is given to an individual who has shown evidence of exceptional promise based on their emerging body of technical and scholarly work in the field of HEOR. The 2022 honoree is:

  • Melanie Whittington, PhD; Institute for Clinical and Economic Review; Boston, MA, USA

     

    LMIC Health Economics and Outcomes Research Excellence Award
    This award recognizes individuals in low- and middle-income countries (LMICs) with demonstrated outstanding HEOR achievements. The 2022 honoree is:

  • Diego Rosselli, MD; Pontificia Universidad Javeriana; Bogotá, Colombia

     

    Award for Excellence in Health Economics and Outcomes Research Methodology
    This award recognizes honorees for their outstanding research in the field of HEOR methodology. The 2022 honoree is:

  • “A Multiple Imputation Procedure for Record Linkage and Causal Inference to Estimate the Effects of Home-Delivered Meals;” Roee Gutman, PhD; Brown University; Providence, RI, USA [Ann Appl Stat. 2021;15(1):412-436]

     

    Award for Excellence in Health Economics and Outcomes Research Application
    This award recognizes honorees for their outstanding practical application of HEOR in healthcare decision making. The 2022 honoree is:

  • “Quantifying the Burden of Hyperphagia in Prader-Willi Syndrome Using Quality-Adjusted Life-Years;” Tara Lavelle, PhD; Tufts Medical Center; Boston, MA, USA [Clin Ther. 2021;43(7):1164-1178]

     

    Value in Health Paper of the Year Award
    The outstanding research paper for Value in Health is:

  • “Are Drugs Priced in Accordance With Value? A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports;” Lisa Bloudek, PharmD; Curta; Seattle, WA, USA [Value Health. 2021; 24(6):789-794]

     

    Value in Health Regional Issues Excellent Article Award
    The excellent article honored for Value in Health Regional Issues is:

  • “Current Status of Research on the Mapping Function of Health Utility Values in the Asia Pacific Region: A Systematic Review;” Fang Zhang, PhD; Shenyang Pharmaceutical University; Shenyang, China [Value Health Reg Issues. 2021;24:224-239]

Nominations for the 2023 ISPOR  Scientific and Leadership Awards are now open. Additional information can be found here.

ISPOR Virtual HEOR Awards Ceremony
The awardees will be honored at the upcoming Virtual Awards Ceremony on Tuesday, November 15 1-2pm EST Registration for the event can be found here.

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram

ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2021 impact factor score is 5.101 and its 5-year impact factor score is 6.747. Value in Health is ranked 5th of 87 journals in health policy and services, 7th of 102 journals in healthcare sciences and services, and 19th of 371 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Website  | Twitter (@isporjournals)

ABOUT VALUE IN HEALTH REGIONAL ISSUES
Value in Health Regional Issues (ISSN 2212-1099) is ISPOR’s online, MEDLINE®-indexed journal that publishes articles on health-related topics that impact the health policies and populations in the following regions: (1) Asia; (2) Central and Eastern Europe, Western Asia, and Africa; and (3) Latin America.
Website  |  Twitter (@isporjournals)

Related Stories

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.

ISPOR Announces 2024 Health Economics and Outcomes Research Award Honorees

Oct 14, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2024 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

Cracking the Code on Medicare's Drug Price Negotiations

Oct 1, 2024

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×